4526

JP:RIKENVITAMIN

理研ビタミン株式会社

  • Stock

Last Close

2,538.00

22/11 06:45

Market Cap

83.17B

Beta: -

Volume Today

34.90K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
17.22B
-
18.40B
6.86%
18.12B
1.55%
17.36B
4.19%
16.77B
3.39%
17.26B
2.93%
18.92B
9.58%
16.89B
10.68%
14.68B
13.10%
16.41B
11.74%
average payables
9.81B
-
8.97B
8.53%
8.53B
4.88%
8.14B
4.65%
8.38B
3.04%
8.95B
6.77%
7.90B
11.75%
6.42B
18.76%
6.61B
3.04%
7.41B
12.10%
average receivables
22.16B
-
22.39B
1.07%
22.52B
0.59%
22.84B
1.42%
24.85B
8.76%
24.95B
0.40%
21.08B
15.51%
18.32B
13.08%
17.94B
2.07%
18.61B
3.74%
book value per share
1.51K
-
1.71K
13.22%
1.68K
1.82%
1.66K
0.66%
1.83K
9.70%
1.87K
2.15%
1.49K
20.06%
1.41K
5.59%
2.03K
44.09%
2.17K
7.24%
capex per share
-126.09
-
-127.01
0.74%
-136.17
7.21%
-90.05
33.87%
-93.03
3.31%
-121.23
30.30%
-164.27
35.51%
-114.96
30.02%
-103.14
10.28%
-66.05
35.96%
capex to depreciation
-1.64
-
-1.44
12.04%
-1.77
23.02%
-0.83
53.35%
-0.84
1.09%
-1.02
21.55%
-1.32
30.31%
-0.95
27.93%
-0.91
5.01%
-0.58
35.63%
capex to operating cash flow
-0.81
-
-0.95
17.13%
-0.72
24.24%
-0.36
50.38%
-0.53
48.63%
-0.59
12.47%
-0.92
54.97%
-0.49
46.30%
-0.50
0.28%
-0.28
44.22%
capex to revenue
-0.07
-
-0.07
0.52%
-0.07
3.82%
-0.03
51.37%
-0.03
2.48%
-0.04
30.22%
-0.06
46.82%
-0.05
25.27%
-0.04
11.97%
-0.02
42.81%
cash per share
369.23
-
349.61
5.32%
323.18
7.56%
535.52
65.70%
442.42
17.38%
460.19
4.02%
402.02
12.64%
498.86
24.09%
527.50
5.74%
475.58
9.84%
days of inventory on hand
108.25
-
112.73
4.14%
102.03
9.50%
105.78
3.68%
94.68
10.49%
105.34
11.25%
128.22
21.72%
93.60
27.00%
102.54
9.54%
105.25
2.64%
days payables outstanding
55.88
-
51.87
7.18%
49.26
5.04%
48.10
2.34%
51.93
7.95%
51.86
0.13%
44.56
14.06%
39.70
10.92%
48.75
22.81%
45.46
6.76%
days sales outstanding
95.29
-
95.88
0.61%
93.51
2.47%
96.82
3.53%
108.33
11.89%
94.71
12.58%
82.84
12.53%
83.63
0.95%
83.26
0.44%
78.76
5.40%
debt to assets
0.12
-
0.12
1.46%
0.11
5.16%
0.30
173.09%
0.24
21.98%
0.22
4.86%
0.22
1.25%
0.23
3.23%
0.17
25.34%
0.14
18.98%
debt to equity
0.18
-
0.18
2.97%
0.16
7.30%
0.62
279.61%
0.44
28.55%
0.41
7.85%
0.47
15.82%
0.53
11.51%
0.26
50.08%
0.20
22.58%
dividend yield
0.02
-
0.01
13.32%
0.02
13.45%
0.02
25.26%
0.02
20.04%
0.02
34.02%
0.02
9.78%
0.03
64.45%
0.03
20.06%
0.03
0.41%
earnings yield
0.07
-
0.04
39.40%
0.05
12.06%
0.07
43.90%
0.08
24.77%
0.07
20.04%
-0.11
262.04%
-0.04
66.88%
0.39
1,190.87%
0.10
74.09%
enterprise value
49.14B
-
89.77B
82.69%
86.26B
3.91%
79.59B
7.73%
77.84B
2.20%
67.33B
13.49%
80.44B
19.47%
49.90B
37.97%
55.24B
10.69%
58.49B
5.89%
enterprise value over ebitda
5.37
-
9.88
83.80%
9.25
6.33%
7.45
19.51%
7.47
0.36%
7.18
3.90%
7.57
5.47%
7.67
1.33%
5.41
29.49%
5.04
6.83%
ev to operating cash flow
7.11
-
15.11
112.43%
10.30
31.85%
9.79
4.88%
13.53
38.14%
10.07
25.60%
13.75
36.60%
6.54
52.41%
8.10
23.70%
7.47
7.79%
ev to sales
0.58
-
1.05
82.30%
0.98
6.61%
0.91
6.79%
0.87
4.75%
0.75
13.85%
0.97
29.42%
0.64
33.77%
0.70
8.58%
0.66
5.47%
free cash flow per share
30.12
-
7.33
75.68%
53.95
636.34%
163.33
202.76%
83.08
49.13%
82.82
0.32%
14.15
82.91%
117.56
730.67%
104.88
10.78%
172.77
64.74%
free cash flow yield
0.03
-
0.00
86.05%
0.03
655.60%
0.08
202.39%
0.04
50.37%
0.05
14.24%
0.01
85.98%
0.09
1,233.33%
0.06
27.38%
0.09
43.66%
graham net net
156.80
-
84.69
45.99%
117.13
38.30%
-391.06
433.87%
-294.13
24.79%
-244.81
16.77%
-549.70
124.54%
-701.45
27.61%
69.32
109.88%
151.82
119.01%
graham number
1.66K
-
1.82K
9.40%
1.88K
3.54%
2.25K
19.64%
2.66K
18.44%
2.25K
15.58%
2.83K
25.65%
1.25K
55.86%
5.48K
339.44%
3.09K
43.55%
income quality
1.30
-
1.13
12.64%
1.37
21.26%
1.32
3.66%
0.70
47.41%
1.11
59.23%
-0.99
189.64%
-1.09K
109,703.72%
0.34
100.03%
1.00
196.88%
intangibles to total assets
0.01
-
0.01
0.76%
0.01
17.63%
0.01
14.53%
0.01
11.49%
0.01
5.75%
0.01
8.43%
0.01
0.10%
0.01
6.37%
0.01
9.84%
interest coverage
11.40
-
9.23
19.04%
10.17
10.17%
10.03
1.35%
8.48
15.49%
6.68
21.16%
8.79
31.51%
3.83
56.40%
32.81
756.28%
54.23
65.28%
interest debt per share
284.10
-
312.55
10.01%
287.55
8.00%
1.06K
267.09%
832.70
21.11%
785.55
5.66%
728.12
7.31%
763.46
4.85%
540
29.27%
447.84
17.07%
inventory turnover
3.37
-
3.24
3.97%
3.58
10.49%
3.45
3.55%
3.85
11.72%
3.47
10.12%
2.85
17.85%
3.90
36.98%
3.56
8.71%
3.47
2.57%
invested capital
0.18
-
0.18
2.97%
0.16
7.30%
0.62
279.61%
0.44
28.55%
0.41
7.85%
0.47
15.82%
0.53
11.51%
0.26
50.08%
0.20
22.58%
market cap
52.23B
-
91.10B
74.43%
88.45B
2.91%
64.46B
27.13%
67.29B
4.39%
58.93B
12.43%
71.84B
21.91%
44.76B
37.69%
55.01B
22.88%
63.09B
14.69%
net current asset value
22.72B
-
20.50B
9.78%
22.78B
11.11%
4.32B
81.02%
8.35B
93.27%
9.25B
10.74%
36M
99.61%
-6.54B
18,252.78%
16.67B
355.07%
24.27B
45.62%
net debt to ebitda
-0.34
-
-0.15
56.78%
-0.24
61.10%
1.42
701.87%
1.01
28.47%
0.90
11.43%
0.81
9.63%
0.79
2.45%
0.02
97.13%
-0.40
1,842.65%
net income per share
81.18
-
85.81
5.71%
93.71
9.20%
135.02
44.08%
172.66
27.88%
120.46
30.23%
-237.93
297.51%
-49.10
79.37%
657.99
1,440.21%
195.51
70.29%
operating cash flow per share
156.20
-
134.34
14.00%
190.12
41.52%
253.38
33.28%
176.12
30.49%
204.04
15.86%
178.42
12.56%
232.52
30.32%
208.02
10.54%
238.83
14.81%
payables turnover
6.53
-
7.04
7.73%
7.41
5.31%
7.59
2.40%
7.03
7.36%
7.04
0.13%
8.19
16.36%
9.19
12.26%
7.49
18.57%
8.03
7.25%
receivables turnover
3.83
-
3.81
0.61%
3.90
2.53%
3.77
3.41%
3.37
10.63%
3.85
14.39%
4.41
14.32%
4.36
0.94%
4.38
0.45%
4.63
5.71%
research and ddevelopement to revenue
return on tangible assets
0.04
-
0.03
5.18%
0.04
13.58%
0.04
4.21%
0.05
27.20%
0.04
29.50%
-0.08
310.77%
-0.02
79.77%
0.21
1,491.67%
0.06
71.02%
revenue per share
1.93K
-
1.94K
0.22%
2.00K
3.26%
2.72K
36.00%
2.74K
0.80%
2.74K
0.06%
2.53K
7.71%
2.37K
6.35%
2.42K
1.92%
2.71K
11.99%
roe
0.05
-
0.05
6.63%
0.06
11.23%
0.08
45.04%
0.09
16.57%
0.06
31.70%
-0.16
347.09%
-0.03
78.14%
0.32
1,030.13%
0.09
72.29%
roic
0.04
-
0.04
12.39%
0.05
25.87%
0.06
21.18%
0.05
14.52%
0.04
21.97%
0.12
204.28%
8.31
6,981.44%
0.07
99.11%
0.07
7.88%
sales general and administrative to revenue
shareholders equity per share
1.51K
-
1.71K
13.22%
1.68K
1.82%
1.66K
0.66%
1.83K
9.70%
1.87K
2.15%
1.49K
20.06%
1.41K
5.59%
2.03K
44.09%
2.17K
7.24%
stock based compensation to revenue
0.00
-
0.00
93.64%
0.00
22.62%
0.00
10.32%
0.00
226.98%
0.00
5.62%
tangible asset value
66.22B
-
74.94B
13.17%
73.50B
1.91%
53.14B
27.71%
59.41B
11.79%
60.97B
2.63%
48.70B
20.11%
45.99B
5.57%
65.84B
43.16%
70.72B
7.42%
tangible book value per share
1.50K
-
1.69K
13.17%
1.67K
1.55%
1.66K
0.67%
1.82K
9.75%
1.86K
2.26%
1.49K
20.13%
1.40K
5.59%
2.01K
43.13%
2.16K
7.40%
working capital
29.01B
-
28.04B
3.36%
28.92B
3.13%
29.39B
1.63%
31.74B
7.99%
30.19B
4.88%
18.92B
37.32%
514M
97.28%
34.57B
6,625.49%
39.20B
13.40%

All numbers in (except ratios and percentages)